Clinical trends of scalp alopecia areata: a tertiary care hospital based observational study

Authors

  • Pallavi Singh Department of Dermatology, Dr. D.Y. Patil Medical College and Hospital, Pune affiliated to Dr. D.Y. Patil Vidyapeeth University, Pune, Maharashtra, India
  • Milind A. Patvekar Department of Dermatology, Dr. D.Y. Patil Medical College and Hospital, Pune affiliated to Dr. D.Y. Patil Vidyapeeth University, Pune, Maharashtra, India
  • Bhavika Shah Department of Dermatology, Dr. D.Y. Patil Medical College and Hospital, Pune affiliated to Dr. D.Y. Patil Vidyapeeth University, Pune, Maharashtra, India
  • Alisha Mittal Department of Dermatology, Dr. D.Y. Patil Medical College and Hospital, Pune affiliated to Dr. D.Y. Patil Vidyapeeth University, Pune, Maharashtra, India
  • Asmita Kapoor Department of Dermatology, Dr. D.Y. Patil Medical College and Hospital, Pune affiliated to Dr. D.Y. Patil Vidyapeeth University, Pune, Maharashtra, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20200607

Keywords:

Alopecia areata, Alopecia areata pattern, Alopecia areata nail changes, Scalp

Abstract

Background: Alopecia areata is one of the commonest types of non-scarring alopecia involving the scalp and/or body. As there is paucity of recent epidemiological data from our country, this study was conducted to determine the latest clinical and epidemiological trends of scalp alopecia areata.

Methods: A hospital-based observational study consisting of 100 cases of clinically diagnosed scalp alopecia areata who reported to the Dermatology OPD, Dr. D.Y. Patil Medical College, Pune, was conducted for a period of six months. Socio-demographic and clinical information was collected and clinical examination was performed on all patients. The data was evaluated using appropriate statistical methods.

Results: Out of the 100 cases enrolled, males (64%) outnumbered females (36%). The commonest presenting age group was 21-30 years (44%). Disease onset was sudden in 80% patients and 59% cases had a progressive disease course. Majority (75%) had a disease duration of less than 3 months. Majority cases were asymptomatic (80%) with no precipitating factors (90%). Past history and family history of alopecia areata were present in 13% and 9% cases, respectively. Personal and family history of associated diseases were present in 27% and 22% patients, respectively. Most patients had single (61%), patchy (83%) lesions with occiput (45%) being the commonest initial site. Nail changes were present in 22% cases, of which pitting (13%) was the commonest nail finding.

Conclusions: This study reflects the clinical profile of scalp alopecia areata in a tertiary care hospital.

Author Biographies

Pallavi Singh, Department of Dermatology, Dr. D.Y. Patil Medical College and Hospital, Pune affiliated to Dr. D.Y. Patil Vidyapeeth University, Pune, Maharashtra, India

Department of Dermatology 

Designation: 3rd year resident

Milind A. Patvekar, Department of Dermatology, Dr. D.Y. Patil Medical College and Hospital, Pune affiliated to Dr. D.Y. Patil Vidyapeeth University, Pune, Maharashtra, India

Designation: Professor

Department of Dermatology

Bhavika Shah, Department of Dermatology, Dr. D.Y. Patil Medical College and Hospital, Pune affiliated to Dr. D.Y. Patil Vidyapeeth University, Pune, Maharashtra, India

Department of Dermatology 

Designation: 3rd year resident

Alisha Mittal, Department of Dermatology, Dr. D.Y. Patil Medical College and Hospital, Pune affiliated to Dr. D.Y. Patil Vidyapeeth University, Pune, Maharashtra, India

Department of Dermatology 

Designation: 3rd year resident

Asmita Kapoor, Department of Dermatology, Dr. D.Y. Patil Medical College and Hospital, Pune affiliated to Dr. D.Y. Patil Vidyapeeth University, Pune, Maharashtra, India

Department of Dermatology 

Designation: 1st year resident

References

Seetharam KA. Alopecia areata: An update. Indian J Dermatol Venereol Leprol. 2013;79:563-75.

Sharma VK, Dawn G, Kumar B. Profile of alopecia areata in Northern India. Int J Dermatol. 1996;35:22-7.

Kaur S, Mahajan BB, Mahajan R. Comparative Evaluation of Intralesional Triamcinolone Acetonide Injection, Narrow Band Ultraviolet B, and their Combination in Alopecia Areata. Int J Trichol. 2015;7(4):148-55.

Tan E, Tay YK, Goh CL, Chin Giam Y. The pattern of alopecia areata in Singapore- A study of 219 Asians. Int J Dermatol. 2002;41:748-53.

Fricke ACV, Miteva M. Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol. 2015;8:397-403.

Fahim S, Montazer F, Tohidinik HR, Naraghi ZS, Abedini R, Nasimi M, et al. Serum and tissue angiotensin-converting enzyme in patients with alopecia areata. Indian J Dermatol Venereol Leprol. 2019;85:295-9.

Strazzulla LC, Wang EHC, Avila L, Sicco KL, Brinstor N, Christiano AM, et al. Alopecia areata: Disease characteristics, clinical evaluation and new perspectives on pathogenesis. J Am Acad Dermatol. 2018;78:1-12.

Wasserman D, Guzman-Sanchez DA, Scott K, McMichael A. Alopecia areata. Int J Dermatol. 2007;46:121-31.

Finner AM. Alopecia Areata: clinical presentation, diagnosis and unusual cases. Dermat Ther. 2011;24:348-54.

Huang KP, Mullangi S, Guo Y, Qureshi AA. Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. JAMA Dermatol. 2013;149:789-94.

Muller SA, Winkelmann RK. Alopecia areata- an evaluation of 736 patients. Arch Dermatol.1963;88:290-7.

Alkhalifah A. Alopecia Areata Update. Dermatol Clin. 2013;31(1):93-108.

Kranseler JS, Sidbury R. Alopecia areata: Update on management. Indian J Paediatr Dermatol. 2017;18:261-6.

Hordinsky M, Ericson M. Autoimmunity: Alopecia areata. J Investig Dermatol Symp Proc. 2004;9:73-8.

Pratt CH, Lloyd E, Messenger AG, Christiano AM, Sundberg JP. Alopecia Areata. Nat Rev Dis Primers. 2017;3:17011.

Hordinsky MK. Overview of alopecia areata. J Investig Dermatol Symp Proc. 2013;16(1):S13-5.

Wang SJ, Shohat T, Vadheim C, Shellow W, Edwards J, Rotter JI. Increased risk for type 1 (insulin-dependent) diabetes in relatives of patients with alopecia areata. Am J Med Genet. 1994;51:234-9.

Guzmán-Sánchez DA, Villanueva-Quintero GD, Alfaro Alfaro N, McMichael A. A clinical study of alopecia areata in Mexico. Int J Dermatol. 2007;46(12):1308-10.

Gandhi V, Baruah MC, Bhattacharaya SN. Nail changes in alopecia areata: incidence and pattern. Ind J Dermatol Venereol Leprol. 2003;69(2):114-5.

Kasumagic-Halilovic E, Prohic A. Nail changes in alopecia areata: frequency and clinical presentation. J Eur Acad Dermatol Venereol. 2009;23(2):240-1.

Darwin E, Hirt PA, Fertig R, Doliner B, Delcanto G, Jimenez JJ. Alopecia Areata: Review of Epidemiology, Clinical Features, Pathogenesis, and New Treatment Options. Int J Trichol. 2018;10(2):51-60.

Madani S, Shapiro J. Alopecia Areata Update. J Am Acad Dermatol. 2000;42:4:549-66.

Downloads

Published

2020-02-24

Issue

Section

Original Research Articles